Clinical Trial Detail

NCT ID NCT00823459
Title Phase II Trial of RAD001 in Patients With Recurrent Low Grade Glioma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements no
Sponsors University of California, San Francisco
Indications

brain glioma

Therapies

Everolimus

Age Groups: adult

No variant requirements are available.